Stobadine protects isoproterenol-induced toxic damage in rats

Biologia - Section Cellular and Molecular Biology

Volumn 55, Issue SUPPL. 8, 2000, Pages 69-73

  Mačičková, Tatiana ^a   Navarová, Jana ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Cardioprotection; In vivo; Isoproterenol; Lysosomal enzymes; Rats; Stobadine

Indexed keywords

ANIMALIA; MAMMALIA; RATTUS NORVEGICUS;

EID: 0347015938     PISSN: 13356399     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. BAKER, J. E., FELIX, C. C., OLINGER, G. N. & KALYANARAMAN, B. 1988. Myocardial ischaemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy. Proc. Natl. Acad. SCI. USA, 8: 2786-2789.
2. BARRETT, A. J. & HEATH, M. F. 1977. Lysosomal enzymes, pp. 19-147. In: DINGLE, J. T. (ed) Lysosomes. A Laboratory Handbook. 2nd ed., Elsevier/North Holland Biochemical Press, Amsterdam.
3. BENEŠ, L. & ŠTOLC, S. 1989. Stobadine. Drugs Future 14: 135-137.
4. FREEMAN, B. A. & CRAPO, J. D. 1982. Biology of disease. Free radicals and tissue injury. Lab. Invest. 47: 412-426.
5. GAJDOŠÍKOVÁ, A., UJHÁZY, E., GAJDOŠÍK, A., CHALUPA, I., BLAŠKO, M., TOMÁŠKOVÁ, A., LÍŠKA, J., DUBOVICKÝ, M. & BAUER, V. 1995. Chronic toxicity and micronucleus assay of the new cardioprotective agent stobadine in rats. Arzneim. Forsch./ Drug Res. 45: 531-536.
6. GUZY, J., CISÁR, J., BARNOVÁ, E. & BENEŠ, L. 1997. Protective effect of stobadine on isoproterenol pre-medicated rabbits. Pharmazie 52: 5.
7. HAMMOND, B. & HESS, M. 1985. The oxygen free radical system: Potential mediator of myocardial injury. J. Am. Coll. Cardiol. 6: 215-220.
8. HORÁKOVÁ, U. & ŠTOLC, S. 1998. Antioxidant and pharmacodynamic effect of pyrido-indole stobadine. A review. Gen. Pharmac. 30: 627-638.
9. KALRA, J., CHAUDHARY, A. K. & PRASAD, K. 1989. Role of oxygen free radicals and pH on the release of cardiac lysosomal enzymes. J. Mol. Cell. Cardiol. 21: 1125-1136.
10. KALRA, J. & PRASAD, K. 1994. Oxygen free radicals and cardiac depression. Clin. Biochem. 27: 163-168.
11. KEKREJA, R. C. & HESS, M. L. 1992. The oxygen free radical system from equation through membrane protein interactions to cardiovascular injury. Cardiovacs. Res. 26: 641-655.
12. MAČIČKOVÁ, T., NAVAROVÁ, J., URBANČÍKOVÁ, M. & HORÁKOVÁ, K. 1999. Comparison of isoproterenol-induced changes in lysosomal enzyme activity in vivo and in vitro. Gen. Physiol. Biophys. 18: 86-91.
13. MEERSON, F. Z., KAGAN, V. E., KOZLOV, Y. P., BELKINA, L. M. & ARCHIPENKO, Y. V. 1982. The role of lipid peroxidation in pathogenesis of ischaemic damage and the antioxidant protection of the heart. Basic. Res. Cardiol. 75: 465-485
14. MILEI, J., NUNEZ, R. G. & RAPAPORT, M. 1978. Pathogenesis of isoproterenol-induced myocardial lesions. Its relation to human "coagulative myocytosis". Cardiology 63: 139-145.
15. NAVAROVÁ, J., MAČIČKOVÁ, T., HORÁKOVÁ, K. & URBANČÍKOVÁ, M. 1999. Stobadine inhibits lysosomal enzyme release in vivo and in vitro. Life Sci. 18/19: 1905-1907.
16. NIRMALA, C. & PUVANAKRISHNAN, R. 1996. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol. Cell. Biochem. 2: 85-93.
17. NORONHA-DUTRA A. A., STEEN, E. M. & WOLF, N. 1984. The correlation between catecholamine and lipid peroxidation induced in heart cells. Basic. Res. Cardiol. 80: 133-136.
18. ONDREJIČKOVÁ, O., DŽURBA, A., SEDLÁK, J., TOKÁROVÁ, J., MAČIČKOVÁ ,T. & BENEŠ, L. 1991. Processes linked to the formation of reactive oxygen species are not necessarily involved in the development of isoproterenol-induced hypertrophy of the heart: the effect of stobadine. Biomed. Biochim. Acta 1003: 238-245.
19. ÖLLINGER, K. &: BRUNK, U. T. 1995. Cellular injury induced by oxidative stress is mediated through lysosomal damage. Free Radical Biol. Med. 19: 565-574.
20. RAVICHANDRAN, L. V., PUVANAKRISHNAN, R. & JOSEPH, K. T. 1991. Influence of isoproterenol-induced myocardial infarction on certain glycohydrolases and cathepsins in rats. Biochem. Med. Metab. Biol. 45: 6-15.
21. RONA, G., CHAPPEL, C. I., BALAZC, T. & GAUDRY, R. 1959. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch. Pathol. 67: 443-449.
22. RONA, G. 1985. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 17: 291-306.
23. SETH, S. D., MAULIK, M., KOTIYAR, C. K. & MAULIK, S. K. 1998. Role of Lipistat in protection against isoproterenol-induced myocardial necrosis in rats. Indian J. Physiol. Pharmacol. 42: 101-106.
24. SINGAL, P. K., KAPUR, N., DHILLON, K. S. BEAMISH, R. E. & DHALLA, N. S. 1982. Role of free radicals in catecholamine induced cardiomyopathy. Can. J. Physiol. Pharmacol. 60: 1390-1397.
25. SINGAL, P. K., BEAMISH, R. E. & DHALLA, N. S. 1983. Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv. Exp. Med. Biol. 161: 391-401.
26. SPATH, J. A., LANE, D. L. & LETER, A. M. 1974. Protective action of methylprednisole on the myocardium during experimental myocardial ischaemia in the cat. Circ. Res. 35: 44-51.
27. ŠTEFEK, M. & BENEŠ, L. 1991. Pyridoindole stobadine is a potent scavenger of hydroxyl radicals. FEBS Lett. 294: 264-266.
28. ŠTOLC, S., BAUER, V., BENEŠ, L. & TICHÝ, M. 1983. Medicine with antiarrhythmic and antihypoxic activity and its method of preparation. Patents: Čs 229 069, SWED. 8204 , 693-9, BELG. 894148, SWISS 651 754, BRD P-323 1088, SPAIN 55301, JAP. 151 4040.
29. WEXLER, B. C. 1970. Serum creatine phosphokinase activity following isoproterenol-induced myocardial infarction in male and female rats with and without arteriosclerosis. Am. Heart J. 79: 69-75.
30. WILDENTHAL, K., DECKER, R. S., POOLE, R. A., GRIFFIN, E. E. & DINGLE, J. T. 1977. Sequential lysosomal alterations during cardiac ischaemia. J. Biochem. Changes Lab. Invest. 6: 656-668.